Ann: Cardiex Receives TGA Approval for CONNEQT Pulse Device, page-7

When / if sales ramp up, $17mil MC in hindsight will be a ridiculous opportunity.

Pretty much a free lottery ticket here IMO, has that potential to 100 bag from ~$20mil MC to $2bil+ if the Pulse becomes a global disruptor in the space, and if it doesn't the IP and $90mil accrued losses are worth more than $17mil for a medtech company in a T/O...

OTC seems to be a latter priority, but that's where I see the big $$$ down the track. Validation and endorsement of the unique metrics Pulse produces from the professionals in the space the first step.